[go: up one dir, main page]

PH12013500916A1 - Method for inhibiting pathogens using a nutritional composition - Google Patents

Method for inhibiting pathogens using a nutritional composition

Info

Publication number
PH12013500916A1
PH12013500916A1 PH1/2013/500916A PH12013500916A PH12013500916A1 PH 12013500916 A1 PH12013500916 A1 PH 12013500916A1 PH 12013500916 A PH12013500916 A PH 12013500916A PH 12013500916 A1 PH12013500916 A1 PH 12013500916A1
Authority
PH
Philippines
Prior art keywords
nutritional composition
inhibiting
inhibiting pathogens
human
pathogens
Prior art date
Application number
PH1/2013/500916A
Inventor
Dattatreya Banavara
Robert J Mcmahon
Cecilia Munoz
Anja Wittke
Original Assignee
Mjn Us Holdings Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US12/980,808 external-priority patent/US20120171163A1/en
Priority claimed from US12/980,813 external-priority patent/US8648036B2/en
Application filed by Mjn Us Holdings Llc filed Critical Mjn Us Holdings Llc
Publication of PH12013500916A1 publication Critical patent/PH12013500916A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/40—Transferrins, e.g. lactoferrins, ovotransferrins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
    • A23J1/00—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites
    • A23J1/20—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites from milk, e.g. casein; from whey
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/19—Dairy proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pediatric Medicine (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biochemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

A method for inhibiting a bacterial invasive or adhesion mechanism involving administering to a human a nutritional composition including a lipid or fat; a protein source; a prebiotic composition; and at least about 10 mg/100kCal of lactoferrin produced by a non-human source.
PH1/2013/500916A 2010-12-29 2011-12-15 Method for inhibiting pathogens using a nutritional composition PH12013500916A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US12/980,808 US20120171163A1 (en) 2010-12-29 2010-12-29 Method for inhibiting a bacterial invasive mechanism using a nutritional composition
US12/980,813 US8648036B2 (en) 2010-12-29 2010-12-29 Use of nutritional compositions including lactoferrin and one or more prebiotics in inhibiting adhesion of pathogens in the gastrointestinal tract
PCT/US2011/065231 WO2012091946A2 (en) 2010-12-29 2011-12-15 Method for inhibiting pathogens using a nutritional composition

Publications (1)

Publication Number Publication Date
PH12013500916A1 true PH12013500916A1 (en) 2024-06-03

Family

ID=45496273

Family Applications (1)

Application Number Title Priority Date Filing Date
PH1/2013/500916A PH12013500916A1 (en) 2010-12-29 2011-12-15 Method for inhibiting pathogens using a nutritional composition

Country Status (13)

Country Link
EP (1) EP2658388A2 (en)
CN (1) CN103327828B (en)
BR (1) BR112013011642B1 (en)
CA (1) CA2822892C (en)
EC (1) ECSP13012798A (en)
MX (1) MX2013006094A (en)
MY (1) MY174494A (en)
PE (1) PE20141192A1 (en)
PH (1) PH12013500916A1 (en)
RU (1) RU2013128920A (en)
SG (2) SG190781A1 (en)
TW (1) TWI626893B (en)
WO (1) WO2012091946A2 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8968722B2 (en) 2010-12-29 2015-03-03 Mead Johnson Nutrition Company Milk-based nutritional compositions containing lactoferrin and uses thereof
JP2016503025A (en) * 2012-12-18 2016-02-01 エム・ジェイ・エヌ ユー．エス． ホールディングス リミテッド ライアビリティー カンパニー Milk-based nutritional composition containing lactoferrin and uses thereof
US20140271978A1 (en) * 2013-03-15 2014-09-18 Mead Johnson Nutrition Company Low-buffer nutritional compositions and uses thereof
US9609888B2 (en) * 2013-07-31 2017-04-04 Mead Johnson Nutrition Company Nutritional compositions containing synergistic combination and uses thereof
US20200276321A1 (en) * 2017-09-10 2020-09-03 Technion Research & Development Foundation Limited Composition and method for a prebiotic delivery system targeted to probiotic bacteria
GB2618609A (en) * 2022-05-13 2023-11-15 Lintbells Ltd Methods and processes for manufacture of a topically adherent selective bactericide
WO2024056786A1 (en) 2022-09-14 2024-03-21 N.V. Nutricia Nutritional composition

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE61701B1 (en) 1986-07-17 1994-11-30 Morinaga Milk Industry Co Ltd Process for producing bovine lactoferrin in high purity
US4977137B1 (en) * 1987-06-03 1994-06-28 Baylor College Medicine Lactoferrin as a dietary ingredient promoting the growth of the gastrointestinal tract
US5407957A (en) 1990-02-13 1995-04-18 Martek Corporation Production of docosahexaenoic acid by dinoflagellates
JP2731035B2 (en) 1991-01-24 1998-03-25 マーテック・コーポレイション Microbial oil mixtures and uses thereof
US5374567A (en) 1993-05-20 1994-12-20 The United States Of America As Represented By The Secretary Of The Navy Operational amplifier using bipolar junction transistors in silicon-on-sapphire
JPH09509165A (en) 1994-02-16 1997-09-16 ファーミング ベスローテン フェンノートシャップ Separation of lactoferrin from milk
DK1480524T3 (en) 2002-03-07 2013-07-15 Upfront Chromatography As Method for isolating lactoferrin
US20070191264A1 (en) * 2005-05-05 2007-08-16 Bristol-Myers Squibb Company, A Delaware Corporation Methods for inhibiting the growth of bacteria
CN101247823A (en) * 2005-05-05 2008-08-20 布里斯托尔-迈尔斯斯奎布公司 Application of bovine lactoferrin in preparation of medicine for inhibiting bacterial growth
US7572474B2 (en) 2005-06-01 2009-08-11 Mead Johnson Nutrition Company Method for simulating the functional attributes of human milk oligosaccharides in formula-fed infants
US20080003329A1 (en) * 2006-06-30 2008-01-03 Ricardo Rueda Enriched infant formulas
WO2008047391A1 (en) * 2006-10-17 2008-04-24 S.I.F.Fr.A. Farmaceutici Srl Nutriceutic composition comprising lactoferrin and proteasic probiotics
CA2706636A1 (en) * 2007-11-26 2009-06-04 Nestec S.A. Age-tailored nutrition system for infants
ITRM20080163A1 (en) * 2008-03-26 2009-09-27 Maurizio Acri USE OF LATTOFERRINA FOR THE PREVENTION OF NEONATAL SEPSIS IN PREMATURED NEWBORNS
US8425955B2 (en) * 2009-02-12 2013-04-23 Mead Johnson Nutrition Company Nutritional composition with prebiotic component
CA2778522A1 (en) * 2009-10-29 2011-05-05 Nestec S.A. Nutritional compositions comprising lactoferrin and probiotics and kits of parts thereof

Also Published As

Publication number Publication date
TW201238503A (en) 2012-10-01
EP2658388A2 (en) 2013-11-06
RU2013128920A (en) 2015-02-10
CA2822892C (en) 2020-04-28
ECSP13012798A (en) 2013-09-30
BR112013011642A2 (en) 2016-07-12
SG10201508194RA (en) 2015-11-27
CN103327828B (en) 2016-05-11
PE20141192A1 (en) 2014-10-01
HK1189456A1 (en) 2014-06-13
MX2013006094A (en) 2013-07-03
TWI626893B (en) 2018-06-21
SG190781A1 (en) 2013-07-31
WO2012091946A3 (en) 2012-09-07
WO2012091946A2 (en) 2012-07-05
CA2822892A1 (en) 2012-07-05
MY174494A (en) 2020-04-23
CN103327828A (en) 2013-09-25
BR112013011642B1 (en) 2020-04-07

Similar Documents

Publication Publication Date Title
PH12013500916A1 (en) Method for inhibiting pathogens using a nutritional composition
IN2014DN03449A (en)
MX350325B (en) Bacterium for use as a probiotic for nutritional and medical applications.
EA201070419A1 (en) COMPOSITION FOR REGULATING METABOLISM OF LIPIDS
MX342733B (en) Nutritional composition to promote healthy development and growth.
PH12013501877A1 (en) Nutritional compositions including branched chain fatty acids and methods of using same
PH12012502318A1 (en) Substantially clear nutritional liquids comprising calcium hmb and soluble protein
WO2013028555A3 (en) Methods for weight loss and ketogenic compositions
BR112014009418A2 (en) peptidomimetic macrocycles
MY158504A (en) Fatty acid niacin conjugates and their uses
MY151018A (en) Use of nutritional compositions for preventing disorders
BR112013028709A2 (en) bacterial strains capable of metabolizing oxalates
MX364200B (en) Novel compositions and methods for the treatment of immune related diseases.
GB201317630D0 (en) Improvements in or relating to visual performance and/or macular pigmentation in a subject and AMD
PH12014500558A1 (en) Composition for use in the promotion of healthy bone growth and/or in the prevention and/or treatment of bone disease
MX338245B (en) Methods and compositions for inducing satiety.
WO2010007332A3 (en) Composition of branched maltodextrins and eukaryotic organisms having a polysaccharide wall, used in the field of well-being
MX343326B (en) Methods for enhancing energy metabolism.
PH12014500796A1 (en) Partially hydrolyzed casein-whey nutritional compositions for reducing the onset of allergies
BR112014027820A2 (en) dietary control of celiac disease and food allergies
MY161933A (en) Fortified Milk-Based Nutritional Compositions
PH12013500917A1 (en) Use of nutritional compositions including lactoferrin in supporting resistance to diseases and conditions
EP2588070B8 (en) USE OF CHICORIC ACID AND LACTIC BACTERIUM IN FOOD SUPPLEMENT FOR lightening and/or whitening skin tone
PH12013500761A1 (en) Cysteine and food intake
CA2905817A1 (en) Reducing the risk of autoimmune disease